Skip to main content
. 2022 Jul 27;10:879523. doi: 10.3389/fpubh.2022.879523

Table 1.

Clinicopathological characteristics of children with OS.

ALL N = 86 Dead N = 24 Alive N = 62 p
Age 10.7 (2.93) 9.58 (3.59) 11.1 (2.55) 0.068
Sex 0.831
   Male 54 (62.8%) 16 (66.7%) 38 (61.3%)
   Female 32 (37.2%) 8 (33.3%) 24 (38.7%)
Region 1.000
   Urban 44 (51.2%) 12 (50.0%) 32 (51.6%)
   Rural 42 (48.8%) 12 (50.0%) 30 (48.4%)
Medical.insurance 0.392
   No 42 (48.8%) 14 (58.3%) 28 (45.2%)
   Yes 44 (51.2%) 10 (41.7%) 34 (54.8%)
Primary.site 0.179
   Limb 80 (93.0%) 24 (100%) 56 (90.3%)
   Axial 6 (6.98%) 0 (0.00%) 6 (9.68%)
lateral 0.057
   Left 46 (53.5%) 10 (41.7%) 36 (58.1%)
   Right 34 (39.5%) 14 (58.3%) 20 (32.3%)
   Not pairs 6 (6.98%) 0 (0.00%) 6 (9.68%)
Stage <0.001
   I 28 (32.6%) 2 (8.33%) 26 (41.9%)
   II 24 (27.9%) 2 (8.33%) 22 (35.5%)
   III 21 (24.4%) 9 (37.5%) 12 (19.4%)
   IV 13 (15.1%) 11 (45.8%) 2 (3.23%)
Surgery 0.310
   Limb salvage 82 (95.3%) 22 (91.7%) 60 (96.8%)
   Amputation 4 (4.65%) 2 (8.33%) 2 (3.23%)
Chemotherapy 0.496
   No 12 (14.0%) 2 (8.33%) 10 (16.1%)
   Yes 74 (86.0%) 22 (91.7%) 52 (83.9%)
Radiotherapy 0.573
   No 82 (95.3%) 24 (100%) 58 (93.5%)
   Yes 4 (4.65%) 0 (0.00%) 4 (6.45%)
Size 71.0 (37.4) 89.9 (28.6) 63.7 (38.0) 0.001
PLR 128 (73.6) 166 (86.8) 113 (62.6) 0.011
NLR 1.61 (0.72) 1.90 (0.73) 1.49 (0.69) 0.021
SII 677 (464) 913 (462) 586 (436) 0.005
Platelet 407 (157) 474 (146) 381 (154) 0.013
Neutrophile 5.14 (1.48) 5.66 (1.24) 4.94 (1.53) 0.026
Lymphocyte 3.56 (1.17) 3.35 (1.43) 3.65 (1.06) 0.367
Metastasis 1.000
   No 78 (90.7%) 22 (91.7%) 56 (90.3%)
   Yes 8 (9.30%) 2 (8.33%) 6 (9.68%)
Survival. months 33.6 (23.4) 21.2 (21.9) 38.4 (22.3) 0.002